Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic.
暂无分享,去创建一个
M. Ferracin | A. Patrizi | C. Rossi | E. Dika | D. Turchetti | M. Lambertini | S. Miccoli | F. Scarfì | Giulia Veronesi
[1] L. Cornelius,et al. Second primary melanomas: Increased risk and decreased time to presentation in patients exposed to tanning beds , 2018, Journal of the American Academy of Dermatology.
[2] A. Haydon,et al. Clinicopathological characteristics and prognosis of patients with multiple primary melanomas , 2018, The British journal of dermatology.
[3] H. Olsson,et al. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status , 2017, Journal of the American Academy of Dermatology.
[4] J. Paoli,et al. Multiple Primary Melanomas: A Common Occurrence in Western Sweden. , 2017, Acta dermato-venereologica.
[5] Elizabeth Lazaridou,et al. Epidemiological trends in skin cancer , 2017, Dermatology practical & conceptual.
[6] P. Queirolo,et al. Identification, genetic testing, and management of hereditary melanoma , 2017, Cancer and Metastasis Reviews.
[7] T. Kyriakides,et al. CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma , 2017, Journal of Genetics.
[8] C. Sessa,et al. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF , 2016, The British journal of dermatology.
[9] H. Tsao,et al. Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling. , 2016, Journal of the American Academy of Dermatology.
[10] P. Ascierto,et al. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup. , 2016, Journal of the American Academy of Dermatology.
[11] A. Giordano,et al. Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature? , 2016, Cancer biology & therapy.
[12] E. M. Warton,et al. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. , 2015, Journal of the American Academy of Dermatology.
[13] J. Malvehy,et al. Update in genetic susceptibility in melanoma. , 2015, Annals of translational medicine.
[14] M. Oliviero,et al. Multiple primary melanomas: do they look the same? , 2013, The British journal of dermatology.
[15] P. Queirolo,et al. Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history , 2013, Pigment cell & melanoma research.
[16] L. Thomas,et al. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants , 2013, Journal of Medical Genetics.
[17] L. Thomas,et al. Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family. , 2012, Journal of the American Academy of Dermatology.
[18] Peter Boyle,et al. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[19] E. Moscarella,et al. Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma. , 2011, Cancer epidemiology.
[20] K. Brown,et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma , 2011, Nature.
[21] R. Bakos,et al. The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil , 2011, Experimental dermatology.
[22] S. Puig,et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma , 2011, Nature.
[23] H. Putter,et al. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A. , 2011, Journal of the American Academy of Dermatology.
[24] A. Stromberg,et al. Second Primary Melanomas: Incidence and Outcome , 2010, The American surgeon.
[25] A. Halpern,et al. Selection criteria for genetic assessment of patients with familial melanoma. , 2009, Journal of the American Academy of Dermatology.
[26] P. Pasquini,et al. The association between residential pesticide use and cutaneous melanoma. , 2007, European journal of cancer.
[27] K. Peris,et al. The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. , 2006, The Journal of investigative dermatology.
[28] R. Scott,et al. CDKN2A common variant and multi‐organ cancer risk—a population‐based study , 2006, International journal of cancer.
[29] A. Goldstein,et al. Genetic susceptibility in familial melanoma from northeastern Italy , 2004, Journal of Medical Genetics.
[30] Hensin Tsao,et al. A population‐based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors , 2003, Cancer.
[31] H. Lynch,et al. Heredity and malignant melanoma: implications for early cancer detection. , 1968, Canadian Medical Association journal.
[32] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.